Oligodendrocyte and Myelin Pathophysiology in Multiple Sclerosis

Eneritz López-Muguruza1,2, Carla Peiró-Moreno1,2, Asier Ruiz3

  • 1Department of Neurosciences, University of the Basque Country UPV/EHU, IIS-BioBizkaia and CIBERNED, Leioa, Spain.

PubMed

Insights

Multiple sclerosis (MS) is a progressive neurodegenerative disease targeting the central nervous system (CNS). Understanding oligodendrocyte and myelin damage is key to developing therapies for tissue repair and halting MS progression.

Area of Science:

  • Neuroimmunology
  • Neurodegeneration
  • Central Nervous System Pathology

Background:

  • Multiple sclerosis (MS) is a chronic, autoimmune, and progressive neurodegenerative disease affecting the central nervous system (CNS).
  • MS pathology primarily targets myelin and oligodendrocytes, but also involves other glial cells and neurons.
  • Inflammation, initiated peripherally, spreads throughout the CNS, activating astrocytes and microglia.

Purpose of the Study:

  • To emphasize pathophysiological changes in oligodendrocytes and myelin due to the inflammatory cascade in MS.
  • To explore mechanisms of oligodendrocyte and myelin damage beyond immune attack for CNS protection.
  • To summarize experimental developments, clinical therapies, and trials for MS tissue repair and halting disease progression.

Main Methods:

  • Review of current literature on MS pathophysiology.
  • Analysis of inflammatory cascade mechanisms impacting CNS.
  • Examination of oligodendrocyte repopulation and remyelination strategies.

Main Results:

  • Inflammation drives oligodendrocyte and myelin damage in MS.
  • Understanding the axon-myelin unit is crucial for preventing axonal degeneration.
  • Oligodendrocyte repopulation and remyelination offer therapeutic potential.

Conclusions:

  • Targeting oligodendrocyte and myelin pathology is essential for MS treatment.
  • Preventing axonal degeneration is critical for managing MS symptoms and CNS atrophy.
  • Further research into remyelination strategies holds promise for halting MS progression.

Related Concept Videos

Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
739
Glial Cells01:04

Glial Cells

Overview
86.6K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
513
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
960
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
495